Robot-assisted left-side partial nephrectomy with a segmental resection of left lower ureter and Boari reconstruction
- Authors: Kurbanov A.A.1, Kryukov S.R.1, Chernov Y.N.1, Chinenov D.V.1, Votyakov A.Y.1, Shpot E.V.1
-
Affiliations:
- Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
- Issue: No 4 (2023)
- Pages: 125-128
- Section: Clinical case
- URL: https://journals.eco-vector.com/1728-2985/article/view/587984
- DOI: https://doi.org/10.18565/urology.2023.4.125-128
- ID: 587984
Cite item
Open Access
Access granted
Abstract
Renal cell carcinoma (RCC) accounts for more than 90% of cases of malignant kidney tumors and represents 2-3% of all malignancies worldwide. Clear cell renal cell carcinoma (ccRCC), the most common type of RCC, comprising 70–80% of cases. RCC most commonly metastasizes to the lungs, bones, lymph nodes, liver, adrenal glands, and brain. Synchronous metastasis of RCC to the ipsilateral ureter represents an extremely rare event. Ureteral metastasis is a significant diagnostic challenge, since it is quite difficult to determine whether it has metastatic origin (RCC) or it is a primary urothelial tumor. Moreover, due to the rarity of disease, treatment strategy is not well established.
We present a rare case of patient with the RCC of a single left kidney and metachronous metastasis to the ipsilateral ureter that was initially assumed to be primary urothelial carcinoma. The robotic-assisted left-side partial nephrectomy with a segmental resection of left lower ureter and Boari reconstruction was performed.
This case of successful treatment with robotic-assisted approach shows a great organ-sparing potential of robotic surgery in the treatment of complex oncological patients for whom it is extremely important to preserve the maximum volume of functioning renal tissue, particularly in those with a metastatic RCC of a single kidney.
Full Text
About the authors
A. A. Kurbanov
Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
Author for correspondence.
Email: asadulla10@mail.ru
Ph.D. student at the Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
Russian Federation, MoscowS. R. Kryukov
Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
Email: s.krukov78@gmail.com
6-year student, FGAOU VO I.M. Sechenov First Moscow State Medical University
Russian Federation, MoscowYa. N. Chernov
Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
Email: yarik.chernov@mail.ru
Ph.D., urologist at the Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
Russian Federation, MoscowD. V. Chinenov
Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
Email: chinenovdv@rambler.ru
Ph.D., associate professor at the Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
Russian Federation, MoscowA. Y. Votyakov
Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
Email: votyakov.a.yu@gmail.com
Ph.D. student at the Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
Russian Federation, MoscowE. V. Shpot
Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
Email: shpot@inbox.ru
Ph.D., MD, professor at the Institute for Urology and Human Reproductive Health of FGAOU I.M. Sechenov First Moscow State Medical University
Russian Federation, MoscowReferences
- Bahadoram S., Davoodi M., Hassanzadeh S., Bahadoram M., Barahman M., Mafakher L. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. G Ital Nefrol. 2022;39(3). Accessed March 7, 2023. https://pubmed.ncbi.nlm.nih.gov/35819037/
- Ljungberg B., Bensalah K., Canfield S., et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–924. doi: 10.1016/J.EURURO.2015.01.005.
- Bianchi M., Sun M., Jeldres C., et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol Off J Eur Soc Med Oncol. 2012;23(4):973–980. doi: 10.1093/annonc/mdr362.
- Hao-Jie Z., Lu S., Zhen-Wang Z., Zhong-Quan S., Wei-Qing Q., Jian-Da S. Contralateral ureteral metastasis 4 years after radical nephrectomy. Int J Surg Case Rep. 2012;3(1):37–38. doi: 10.1016/j.ijscr.2011.10.012.
- Lee K.H., Lai W.H., Chiu A.W.S., Lu C.C., Huang S.K.H. Robot-assisted retroperitoneoscopic surgery for synchronous contralateral ureteral metastasis of renal-cell carcinoma. J Endourol Case Rep. 2015;1(1):65–67. doi: 10.1089/cren.2015.0023.
- Dixon A., Tretiakova M., Gore J., Voelzke B.B. Metastatic renal cell carcinoma to the contralateral ureter: a rare phenomenon. Urol Case Rep. 2016;4:36–37. doi: 10.1016/j.eucr.2015.10.005.
- WA Mayer MRDCPRAKJH. Synchronous metastatic renal cell carcinoma to the genitourinary tract: two rare case reports and a review of the literature. Can J Urol. 2009;16:4611–4614.
- Zorn K.C., Orvieto M.A., Mikhail A.A., et al. Solitary ureteral metastases of renal cell carcinoma. Urology. 2006;68(428):e5–7. doi: 10.1016/j.urology.2006.03.012.
- Gelister J.S.K., Falzon M., Crawford R., Chapple C.R., Hendry W.F. Urinary tract metastasis from renal carcinoma. Br J Urol. 1992;69(3):250–252. doi: 10.1111/j.1464-410x.1992.tb15522.x.
- Sountoulides P., Metaxa L., Cindolo L. Atypical presentations and rare metastatic sites of renal cell carcinoma: A review of case reports. J Med Case Rep. 2011;5(1):1–9. doi: 10.1186/1752-1947-5-429/TABLES/5.
- Blanc J., Roth B. Clear cell renal cancer metastasis in the contralateral ureter: a case report. J Med Case Rep. 2021;15(1):1–5. doi: 10.1186/S13256-021-02839-W/FIGURES/4.
- Prokopovich M.A., Malkhasyan V.A., Semenyakin I.V., Pushkar D.Yu. Robot-assisted partial nephrectomy in obese patients. Urology and Andrology. 2019;7(1):12–16. doi: 10.20953/2307-6631-2019-1-12-16.
Supplementary files
